The Undervalued Hormone in Women’s Health
Estrogen gets most of the attention in discussions of women’s hormone therapy — hot flashes, vaginal atrophy, bone density, cardiovascular health. But progesterone — the other key ovarian hormone — plays a equally critical role in female physiology, and its decline (which typically begins years before estrogen drops) underlies many of the most disruptive symptoms of perimenopause. Understanding what progesterone actually does, and how bioidentical progesterone therapy differs from synthetic progestins, is essential for any woman considering or already on HRT.
What Progesterone Does in the Body
Progesterone is produced primarily by the corpus luteum after ovulation and, during pregnancy, by the placenta. Its functions extend far beyond cycle regulation:
Uterine protection: Progesterone opposes estrogen’s proliferative effect on the uterine lining (endometrium), preventing endometrial hyperplasia and reducing endometrial cancer risk. This is why systemic estrogen therapy in women with a uterus requires progesterone or a progestogen alongside it.
CNS effects — mood and anxiety: Progesterone and its primary metabolite allopregnanolone are potent positive modulators of GABA-A receptors — the same receptors targeted by benzodiazepines and alcohol. Progesterone has natural anxiolytic, sedative, and mood-stabilizing properties. The anxiety, irritability, and sleep disruption of perimenopause are largely driven by progesterone’s decline.
Sleep regulation: Progesterone promotes slow-wave sleep. Oral micronized progesterone (Prometrium), taken at bedtime, is one of the most effective and underutilized treatments for perimenopausal insomnia — producing measurable improvements in sleep quality through its GABAergic metabolites.
Thyroid function: Progesterone facilitates thyroid hormone receptor activation and opposes the thyroid-suppressing effects of high estrogen.
Breast tissue: Bioidentical progesterone (unlike synthetic progestins) appears to have a neutral or potentially protective effect on breast tissue — an important distinction from synthetic medroxyprogesterone acetate, which contributed to increased breast cancer risk in the WHI study.
Bone density: Progesterone stimulates osteoblast activity, complementing estrogen’s role in preventing bone resorption.
Bioidentical vs. Synthetic Progestins: Why It Matters
Bioidentical progesterone (oral micronized progesterone, also known by brand name Prometrium, or compounded forms) has an identical molecular structure to the progesterone produced by the human body. Synthetic progestins — medroxyprogesterone acetate (MPA), norethindrone, levonorgestrel — are structurally distinct molecules designed to bind progesterone receptors but with different binding profiles at other hormone receptors, producing different systemic effects.
The distinction matters clinically in several ways: synthetic progestins have adverse effects on lipid profiles and cardiovascular markers that bioidentical progesterone does not; synthetic progestins interfere with sleep rather than improving it; and the WHI breast cancer signal was specific to combined estrogen + MPA, not to estrogen + bioidentical progesterone, which the ENDO trial and observational data suggest carries a more favorable breast risk profile.
Progesterone Therapy Protocols at Multigen Wellness
For perimenopausal women with an intact uterus on estradiol therapy, micronized progesterone is prescribed either cyclically (for women still menstruating) or continuously (for postmenopausal women) at doses that adequately protect the endometrium and optimize symptomatic benefits. Dosing and timing (morning vs. bedtime) are individualized based on the primary symptom target — bedtime dosing for sleep; morning for anxiety management.
To learn whether progesterone therapy is appropriate for your hormone picture, call Multigen Wellness at (800) 259-0015. Same-week telehealth consultations available.